Nielsen Kirk G.

SEC Form 4 insider trading activity

Nielsen Kirk G. has filed 2 SEC Form 4 filings (6 transaction rows) across 2 companies, including CVRX, SGP, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 3, 2026.

On the most recent filing, Nielsen Kirk G. is listed as Director at SpyGlass Pharma, Inc. Inside the rolling window, Nielsen Kirk G. reported 1 open-market purchase totaling $2.6M in SGP and no open-market sales.

Companies traded

Other insiders at CVRX

Insider Buying

$2.6M

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

2

in the rolling window

Source
SGP
Nielsen Kirk G.
Purchase$2.6MFeb 10SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Nielsen Kirk G. made?

Nielsen Kirk G. has filed 2 SEC Form 4 filings (6 transaction rows) across 2 companies, including CVRX, SGP since 2026.

Which companies does Nielsen Kirk G. trade?

Nielsen Kirk G. has filed SEC Form 4 disclosures for 2 companies, including CVRX, SGP.

When was Nielsen Kirk G.'s most recent SEC Form 4 filing?

Nielsen Kirk G.'s most recent SEC Form 4 filing on Tracefour is dated Jun 3, 2026.

What is Nielsen Kirk G.'s total buy and sell value in the current window?

Inside the rolling retention window, Nielsen Kirk G. bought $2.6M and sold $0 based on SEC Form 4 filings.

What was Nielsen Kirk G.'s largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 165,000 SGP shares on 2026-02-09, worth $2.6M, per SEC Form 4 filings.